> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Calcimar Not Withdraw Due to Safety/Efficacy
- URL: https://www.fdaweb.com/calcimar-not-withdraw-due-to-safety-efficacy/
- Published: 2019-09-11T12:00:00.000Z
- Updated: 2026-09-15T01:49:21.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5144975

*Federal Register* notice: FDA has determined that Sanofi Aventis’ Calcimar (calcitonin salmon) injection, 200 IU/mL was not withdrawn from sale due to safety or effectiveness reasons. The determination will allow FDA to approve ANDAs that reference Calcimar if all other legal and regulatory requirements are met. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2019-09-09/pdf/2019-19347.pdf?ref=fdaweb.com).